Literature DB >> 30378120

von Willebrand factor clearance - biological mechanisms and clinical significance.

Jamie M O'Sullivan1, Soracha Ward1, Michelle Lavin1,2, James S O'Donnell1,2.   

Abstract

The mechanisms involved in regulating von Willebrand factor (VWF) clearance remain poorly understood. However recent studies have shown that macrophages play a critical role in regulating the half-life of VWF, and have identified specific lectin (including asialoglycoprotein, macrophage galactose-type lectin, Sigec-5 and C-type lectin domain family 4 member M) and scavenger receptors (including low-density lipoprotein receptor-related protein-1, scavenger receptor A1 and stabilin-2) that are involved in VWF clearance. Further studies will be required to determine the relative importance of these individual receptors with respect to physiological and pathological VWF clearance. Nevertheless, recent clinical data have highlighted the importance of enhanced VWF clearance in the pathogenesis of type 1 von Willebrand disease (VWD). Moreover, increased clearance also contributes to reduced VWF levels in many patients with type 2 and type 3 VWD. Improved understanding regarding VWF clearance is not only of direct biological relevance, but may also have important implications for the development of novel therapeutic agents with extended plasma half-lives for the treatment of both VWD and haemophilia A.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  clearance; macrophage; von Willebrand disease; von Willebrand factor

Mesh:

Substances:

Year:  2018        PMID: 30378120     DOI: 10.1111/bjh.15565

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

2.  Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation.

Authors:  Judicael Fazavana; Teresa M Brophy; Alain Chion; Niamh Cooke; Virginie Terraube; Justin Cohen; Chuenlei Parng; Debra Pittman; Orla Cunningham; Matthew Lambert; James S O'Donnell; Jamie M O'Sullivan
Journal:  J Thromb Haemost       Date:  2020-03-30       Impact factor: 5.824

Review 3.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

4.  Endocytosis by macrophages: interplay of macrophage scavenger receptor-1 and LDL receptor-related protein-1.

Authors:  Eelke P Béguin; Małgorzata A Przeradzka; Esmée F J Janssen; Henriët Meems; Magdalena Sedek; Carmen van der Zwaan; Koen Mertens; Maartje van den Biggelaar; Alexander B Meijer; Marjon J Mourik
Journal:  Haematologica       Date:  2019-06-27       Impact factor: 9.941

Review 5.  Low VWF: insights into pathogenesis, diagnosis, and clinical management.

Authors:  James S O'Donnell
Journal:  Blood Adv       Date:  2020-07-14

6.  The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

Authors:  Lakshmi Srivaths; Charles G Minard; Sarah H O'Brien; Allison P Wheeler; Eric Mullins; Mukta Sharma; Robert Sidonio; Shilpa Jain; Ayesha Zia; Margaret V Ragni; Roshni Kulkarni; Jennifer E Dietrich; Peter A Kouides
Journal:  Blood Adv       Date:  2020-07-14

7.  Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.

Authors:  Karl C Desch; Ayse B Ozel; Matt Halvorsen; Paula M Jacobi; Krista Golden; Mary Underwood; Marine Germain; David-Alexandre Tregouet; Pieter H Reitsma; Clive Kearon; Lauren Mokry; J Brent Richards; Frances Williams; Jun Z Li; David Goldstein; David Ginsburg
Journal:  Blood       Date:  2020-07-30       Impact factor: 25.476

Review 8.  Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia.

Authors:  Peter L Turecek; Jill M Johnsen; Steven W Pipe; James S O'Donnell
Journal:  Haemophilia       Date:  2020-06-28       Impact factor: 4.287

Review 9.  The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.

Authors:  Soracha E Ward; Jamie M O'Sullivan; James S O'Donnell
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113

10.  Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor.

Authors:  Diarmaid O'Donghaile; P Vincent Jenkins; Rachel T McGrath; Lisa Preston; Stephen P Field; Soracha E Ward; Jamie M O'Sullivan; James S O'Donnell
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.